221 related articles for article (PubMed ID: 23607508)
1. High expression of p63 is correlated to poor prognosis in squamous cell carcinoma of the tongue.
Loljung L; Coates PJ; Nekulova M; Laurell G; Wahlgren M; Wilms T; Widlöf M; Hansel A; Nylander K
J Oral Pathol Med; 2014 Jan; 43(1):14-9. PubMed ID: 23607508
[TBL] [Abstract][Full Text] [Related]
2. Quantitative expression study of four cytokeratins and p63 in squamous cell carcinoma of the tongue: suitability for sentinel node navigation surgery using one-step nucleic acid amplification.
Yamauchi K; Fujioka Y; Kogashiwa Y; Kohno N
J Clin Pathol; 2011 Oct; 64(10):875-9. PubMed ID: 21705376
[TBL] [Abstract][Full Text] [Related]
3. Expression of p63 (TA and deltaN isoforms) in human primary well differentiated buccal carcinomas.
Chen YK; Hsue SS; Lin LM
Int J Oral Maxillofac Surg; 2004 Jul; 33(5):493-7. PubMed ID: 15183414
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of Hippo pathway effector TAZ in tongue squamous cell carcinoma: correlation with clinicopathological features and patients' prognosis.
Wei Z; Wang Y; Li Z; Yuan C; Zhang W; Wang D; Ye J; Jiang H; Wu Y; Cheng J
J Oral Pathol Med; 2013 Nov; 42(10):747-54. PubMed ID: 23551691
[TBL] [Abstract][Full Text] [Related]
5. [Postoperative recurrence-related factors of 125 patients with cT1-2N0 squamous cell carcinoma of the oral tongue].
Han JM; Wu GH; Zeng ZY; Chen FJ; Chen WK; Li H; Song M; Sun CZ
Ai Zheng; 2007 Jun; 26(6):661-5. PubMed ID: 17562277
[TBL] [Abstract][Full Text] [Related]
6. Expression of the p40 isoform of p63 has high specificity for cutaneous sarcomatoid squamous cell carcinoma.
Ha Lan TT; Chen SJ; Arps DP; Fullen DR; Patel RM; Siddiqui J; Carskadon S; Palanisamy N; Harms PW
J Cutan Pathol; 2014 Nov; 41(11):831-8. PubMed ID: 25263756
[TBL] [Abstract][Full Text] [Related]
7. [Squamous-cell carcinoma of the tongue: treatment results and prognosis].
Zwetyenga N; Majoufre-Lefebvre C; Siberchicot F; Demeaux H; Pinsolle J
Rev Stomatol Chir Maxillofac; 2003 Feb; 104(1):10-7. PubMed ID: 12644785
[TBL] [Abstract][Full Text] [Related]
8. [Survival analysis of 229 patients with advanced squamous cell carcinoma of the oral tongue].
Yang AK; Liu TR; Chen FJ; Ma XF; Guo ZM; Song M; Li QL; Zeng ZY
Ai Zheng; 2008 Dec; 27(12):1315-20. PubMed ID: 19080001
[TBL] [Abstract][Full Text] [Related]
9. Survival pattern and prognostic factors of patients with squamous cell carcinoma of the tongue: a retrospective analysis of 210 cases.
Ling W; Mijiti A; Moming A
J Oral Maxillofac Surg; 2013 Apr; 71(4):775-85. PubMed ID: 23265849
[TBL] [Abstract][Full Text] [Related]
10. Differential expression of p63 isoforms in normal tissues and neoplastic cells.
Nylander K; Vojtesek B; Nenutil R; Lindgren B; Roos G; Zhanxiang W; Sjöström B; Dahlqvist A; Coates PJ
J Pathol; 2002 Dec; 198(4):417-27. PubMed ID: 12434410
[TBL] [Abstract][Full Text] [Related]
11. Clinicopathological features and proliferation markers in tongue squamous cell carcinomas.
Gueiros LA; Coletta RD; Kowalski LP; Lopes MA
Int J Oral Maxillofac Surg; 2011 May; 40(5):510-5. PubMed ID: 21277167
[TBL] [Abstract][Full Text] [Related]
12. Maspin expression in early oral tongue cancer and its relation to expression of mutant-type p53 and vascular endothelial growth factor (VEGF).
Cho JH; Kim HS; Park CS; Kim JK; Jung KY; Shin BK; Kim HK
Oral Oncol; 2007 Mar; 43(3):272-7. PubMed ID: 17174141
[TBL] [Abstract][Full Text] [Related]
13. p40 is a more specific marker than p63 for cutaneous poorly differentiated squamous cell carcinoma.
Alomari AK; Glusac EJ; McNiff JM
J Cutan Pathol; 2014 Nov; 41(11):839-45. PubMed ID: 25263848
[TBL] [Abstract][Full Text] [Related]
14. p63 overexpression associates with poor prognosis in head and neck squamous cell carcinoma.
Lo Muzio L; Santarelli A; Caltabiano R; Rubini C; Pieramici T; Trevisiol L; Carinci F; Leonardi R; De Lillo A; Lanzafame S; Bufo P; Piattelli A
Hum Pathol; 2005 Feb; 36(2):187-94. PubMed ID: 15754296
[TBL] [Abstract][Full Text] [Related]
15. Correlation of ALDH1, CD44, OCT4 and SOX2 in tongue squamous cell carcinoma and their association with disease progression and prognosis.
Huang CF; Xu XR; Wu TF; Sun ZJ; Zhang WF
J Oral Pathol Med; 2014 Aug; 43(7):492-8. PubMed ID: 24450601
[TBL] [Abstract][Full Text] [Related]
16. Maspin, p53, p63, and Ki-67 in epithelial lesions of the tongue: from hyperplasia through dysplasia to carcinoma.
Vered M; Allon I; Dayan D
J Oral Pathol Med; 2009 Mar; 38(3):314-20. PubMed ID: 18783348
[TBL] [Abstract][Full Text] [Related]
17. Carcinoma of the oral tongue: a case series analysis of prognostic factors and surgical outcomes.
Süslü N; Hoşal AŞ; Aslan T; Sözeri B; Dolgun A
J Oral Maxillofac Surg; 2013 Jul; 71(7):1283-90. PubMed ID: 23522769
[TBL] [Abstract][Full Text] [Related]
18. Ki-67 expression predicts radiosensitivity in oral squamous cell carcinoma.
Freudlsperger C; Freier K; Hoffmann J; Engel M
Int J Oral Maxillofac Surg; 2012 Aug; 41(8):965-9. PubMed ID: 22591716
[TBL] [Abstract][Full Text] [Related]
19. p63 isoforms in triple-negative breast cancer: ΔNp63 associates with the basal phenotype whereas TAp63 associates with androgen receptor, lack of BRCA mutation, PTEN and improved survival.
Coates PJ; Nenutil R; Holcakova J; Nekulova M; Podhorec J; Svoboda M; Vojtesek B
Virchows Arch; 2018 Mar; 472(3):351-359. PubMed ID: 29484502
[TBL] [Abstract][Full Text] [Related]
20. Histone deacetylase-1 and -2 expression in mobile tongue squamous cell carcinoma: associations with clinicopathological parameters and patients survival.
Theocharis S; Klijanienko J; Giaginis C; Rodriguez J; Jouffroy T; Girod A; Alexandrou P; Sastre-Garau X
J Oral Pathol Med; 2011 Oct; 40(9):706-14. PubMed ID: 21457345
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]